EDSWT - Erectile Dysfunction Shock Wave Therapy
Erectile Dysfunction Shock Wave Therapy (EDSWT) is an innovative approach to treat vasculogenic ED, delivered by Medispec’s ED1000, a device that uses advanced acoustics technology. EDSWT applies low-intensity extracorporeal (outside the body) shock waves to the tissue.
The ED1000 by Medispec delivers low-intensity Extracorporeal Shock Waves to the penile tissue, to improve the blood flow to the penis. Vasculogenic and diabetic ED patients (no hormonal, neurologic or psychological causes), who are responsive to PDE5 inhibitors as well as those who are unresponsive, can receive shock wave therapy from the ED1000 and experience improved erectile function.
One will not be eligible for ESWT if he has one or more of the following conditions:
-
Any cause of ED other than vascular
-
Penile tumor
-
Prostate tumor
-
Testicle tumor
-
Local tumor at the treatment area
EDSWT was officially accepted by the European Association of Urology (EAU) as the gold standard for treatment of Erectile Dysfunction in the EAU 2013 guidelines on Male Sexual Dysfunction. This was based on clinical trials using the Medispec’s ED1000.
Multi-Application Device
ED1000 is a multi-applications device that can be used for additional indications. Switching from treating one clinical indication to another, can now be done in a user-friendly, straightforward manner, by simply replacing the designated shock wave applicator; Once the system detects a specific applicator, the relevant software and application are launched.
-
Urological Indications –
-
Prostatitis (CPPS)
-
Peyronie’s disease
-
-
Vascular Indications –
-
Peripheral Artery Disease and Chronic Limb Ischemia associated with intermittent claudication
-
Diabetic foot ulcers and neuropathy
-
Wound healing – acute and chronic wounds
-
• Orthopedics indications – treating inflammation and pain for various applications, including non-union fractures
The ED1000 is listed with the United States FDA
